Perspective Therapeutics, Inc.
CATX
$2.99
-$0.13-4.17%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.62% | -51.27% | -52.60% | -103.15% | -100.68% |
| Total Depreciation and Amortization | 42.67% | 72.99% | 87.84% | 194.49% | 366.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.65% | -38.45% | -39.84% | 91.49% | 102.12% |
| Change in Net Operating Assets | 248.74% | -240.69% | -94.46% | -123.50% | -104.95% |
| Cash from Operations | -43.68% | -71.93% | -350.88% | -12,031.18% | -357.06% |
| Capital Expenditure | 43.77% | 69.48% | 76.13% | 42.67% | -432.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 80.09% | 61.83% | 133.20% | -171.79% | -213.84% |
| Cash from Investing | 69.34% | 64.58% | 118.83% | -56.57% | -233.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -31.71% | -30.00% | -27.50% | -20.00% |
| Issuance of Common Stock | 1,380.10% | 1,399.50% | -93.81% | -93.60% | -93.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,386.83% | 23.80% | -96.44% | -96.32% | -96.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.79% | 109.77% | -159.34% | -195.87% | -199.84% |